1,768
Views
12
CrossRef citations to date
0
Altmetric
Research Papers

An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination

, , , , , , , & show all
Pages 1738-1748 | Received 07 Oct 2015, Accepted 05 Feb 2016, Published online: 25 Mar 2016

References

  • Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics 1997; 99(6):765-73; PMID:9164767
  • World Health Organization (WHO) Revised aide-memoire on AEFI investigation. Switzerland: Essential Medicines and Health Products (EMP) Department, 2015. Accessed May 12, 2015.
  • Conference of Deputy Ministers of Health (Canada), Advisory Committee on Population Health and Health Security. National Immunization Strategy: Final Report 2003. Ottawa, Ont: Public Health Agency of Canada; 2003.
  • Scheifele DW, Halperin SA. Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety. Semin Pediatr Infect Dis. 2003;14(3):213-9; PMID:12913834; http://dx.doi.org/10.1016/S1045-1870(03)00036-0
  • Scheifele D.W. IMPACT after 17 years: lessons learned about successful networking. Paediatr Child Health 2009. 14(1):33-5.
  • Bettinger JA, Vanderkooi OG, MacDonald J, Kellner JD. Rapid Online Identification of Adverse Events Following Influenza Immunization in Children by PCIRN's National Ambulatory Network. Pediatr Infect Dis J 2014; 33:1060-4; PMID:25361187
  • Wilson K, Atkinson KM, Deeks SL, Crowcroft NS. Improving vaccine registries through mobile technologies: a vision for mobile enhanced Immunization information systems. Journal of the American Medical Informatics Association : JAMIA. 2016; 23:207-11.
  • Wilson K, Atkinson K, Deeks S. Opportunities for utilizing new technologies to increase vaccine confidence. Expert Rev Vaccines. 2014(0):1-9.
  • Wilson K, Atkinson KM, Westeinde J. Apps for immunization: Leveraging mobile devices to place the individual at the center of care. Human vaccines & immunotherapeutics. 2015;11(10):2395-9; PMID:26110351
  • Atkinson KM, Ducharme R, Westeinde J, Wilson SE, Deeks SL, Pascali D, et al. Vaccination attitudes and mobile readiness: A survey of expectant and new mothers. Hum Vaccin immunother 2015; 11(4): 1039-45.
  • Kantar Worldpanel ComTech. Smartphone OS sales market share. Kantar Worldpanel http://www.kantarworldpanel.com/global/smartphone-os-market-share/intro. Accessed January 5, 2015.
  • Davis FD. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS quarterly. 1989; 13:319-40; http://dx.doi.org/10.2307/249008
  • Parasuraman A, Colby CL. An updated and streamlined technology readiness index TRI 2.0. Journal of Service Research. 2014; 18(1): 59-74; PMID:25530983
  • Law BJ, Laflèche J, Ahmadipour N, Anyoti H. Canadian Adverse Events Following Immunization Surveillance System (CAEFISS): Annual report for vaccines administered in 2012. Canada Communicable Disease Report 2015; 40(S3):7.
  • National Advisory Committee on Immunization (NACI) Vaccine safety and adverse events following immunization. Part 2. Recommended Immunization. Active Immunizing Agents-Influenza Vaccine. Canadian Immunization Guide. 7th ed. Her Majesty the Queen in Right of Canada represented by the Minister of Public Works and Government Services Canada, 80-4.
  • Regan AK, Blyth CC, Effler PV. Using SMS technology to verify the safety of seasonal trivalent influenza vaccine for pregnant women in real time. Med J Aust. 2013;199(11):744-6; PMID:24329634; http://dx.doi.org/10.5694/mja13.10712
  • Clothier HJ, Selvaraj G, Easton ML, Lewis G, Crawford NW, Buttery JP. Consumer reporting of adverse events following immunization. Hum Vaccin Immunother 2014;10(12):3726-30; PMID:25483686
  • Regan AK, Blyth CC, Mak DB, Richmond PC, Effler PV. Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women. Aust N Z J Obstet Gynaecol 2014; 54(6):, 522-8; Epub 2014 Oct 11; PMID:25306915; http://dx.doi.org/10.1111/ajo.12266
  • Leeb A, Regan AK, Peters IJ, Leeb C, Leeb G, Effler PV. Using automated text messages to monitor adverse events following immunisation in general practice. Med J Aust. 2014; 200(7):416-8; PMID:24794676; http://dx.doi.org/10.5694/mja13.11166
  • Baron S, Goutard F, Nguon K, Tarantola A. Use of a text message-based pharmacovigilance tool in Cambodia: pilot study. J Med Internet Res 2013;15(4); PMID:23591700; http://dx.doi.org/10.2196/jmir.2477
  • Pereira JA, Quach S, Hamid JS, Quan SD, Diniz AJ, Van Exan R, et al. The integration of barcode scanning technology into Canadian public health immunization settings. Vaccine. 2014; 32:2748-55.
  • Pereira JA, Quach S, Hamid JS, Heidebrecht CL, Quan SD, Nassif J, Diniz AJ, Van Exan R, Malawski J, Gentry A, et al. Exploring the feasibility of integrating barcode scanning technology into vaccine inventory recording in seasonal influenza vaccination clinics. Vaccine. 2012; 30(4):794-802; PMID:22119585; http://dx.doi.org/10.1016/j.vaccine.2011.11.043
  • Parrella A, Gold M, Braunack-Mayer A, Baghurst P, Marshall H. Consumer reporting of adverse events following immunization (AEFI) Identifying predictors of reporting an AEFI. Human vaccines & immunotherapeutics. 2014; 10(3):747-54; PMID:24406315
  • Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT. Understanding vaccine safety information from the vaccine adverse event reporting system. Pediatr Infect Dis J. 2004; 23(4):287-94; PMID:15071280; http://dx.doi.org/10.1097/00006454-200404000-00002
  • Braun, M.M (2006) Vaccine Adverse Event Reporting System (VAERS). Usefulness and Limitations. Insitute for Vaccine Safety. http://www.vaccinesafety.edu/VAERS.htm. 2006.
  • Google Play Store (2015). IDsurv app info page. Accessed May 12, 2015 from https://play.google.com/store/apps/details?id=com.idsurv&hl=en.
  • Thacker D, Vashishtha V, Bansal C, Yewale V, Saxena V. Novel surveillance system demonstrates burden of enteric fever in India. Int J Infect Dis 2014; 21:47; http://dx.doi.org/10.1016/j.ijid.2014.03.515
  • Thacker DN, Vashishtha V, Bansal CP, Yewale V, Saxena V. Novel surveillance system demonstrates burden of enteric fever in India.16th International Congress on Infectious Diseases. 2014; 21:47.
  • De Serres G, Gariepy M-C, Coleman B, Rouleau I, McNeil S, Benoît M, McGeer A, Ambrose A, Needham J, Bergeron C, et al. Short and Long-Term Safety of the 2009 AS03-Adjuvanted Pandemic Vaccine. PLoS One 2012; 7(7):e38563; PMID:22802929; http://dx.doi.org/10.1371/journal.pone.0038563
  • Bettinger J, Rouleau I, Gariépy M, Bowie W, Valiquette L, Vanderkooi O, et al. Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012. Euro surveillance: bulletin Europeen sur les maladies transmissibles=European communicable disease bulletin. 2014; 20(29); PMID:NOT_FOUND
  • Parasuraman A. Technology Readiness Index (TRI) a multiple-item scale to measure readiness to embrace new technologies. J Serv Res 2000; 2(4):307-20; http://dx.doi.org/10.1177/109467050024001
  • Ottawa Hospital Research Institute. Canadian National Vaccine Safety Network iTunes Preview; URL:https://itunes.apple.com/ca/app/canadian-national-vaccine/id938262382?mt=8. Accessed December 2014.
  • Lookback Inc. User search simplified. https://lookback.io/ 2015.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.